The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes
Abstract MECP2 mutations cause Rett syndrome (RTT), a severe and progressive neurodevelopmental disorder mainly affecting females. Although RTT patients exhibit delayed onset of symptoms, several evidences demonstrate that MeCP2 deficiency alters early development of the brain. Indeed, during early...
Main Authors: | Linda Scaramuzza, Giuseppina De Rocco, Genni Desiato, Clementina Cobolli Gigli, Martina Chiacchiaretta, Filippo Mirabella, Davide Pozzi, Marco De Simone, Paola Conforti, Massimiliano Pagani, Fabio Benfenati, Fabrizia Cesca, Francesco Bedogni, Nicoletta Landsberger |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2021-04-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.202012433 |
Similar Items
-
Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders
by: Xiangling Meng, et al.
Published: (2016-06-01) -
Microglia contribute to circuit defects in Mecp2 null mice independent of microglia-specific loss of Mecp2 expression
by: Dorothy P Schafer, et al.
Published: (2016-07-01) -
Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons
by: Richard D. Smrt, et al.
Published: (2007-07-01) -
Mutation analysis of the MECP2 gene in Romanian females with Rett syndrome
by: Dumitriu Simona, et al.
Published: (2013-12-01) -
Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome
by: Yann Ehinger, et al.
Published: (2021-04-01)